Cleavage of the Fifth Component of Human Complement and Release of a Split Product with C5a-like Activity by Crystalline Silica through Free Radical Generation and Kallikrein Activation

The effects of the same form of crystalline silica variously modified were compared to investigate the mechanisms by which silica activates C5 molecules. After incubation in human plasma, silica generated C5a-type fragments that stimulated polymorphonuclear leukocyte chemotaxis. This activity was to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Toxicology and applied pharmacology 2002-03, Vol.179 (3), p.129-136
Hauptverfasser: Governa, Mario, Fenoglio, Ivana, Amati, Monica, Valentino, Matteo, Bolognini, Lucia, Coloccini, Sabrina, Volpe, Anna Rita, Carmignani, Marco, Fubini, Bice
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 136
container_issue 3
container_start_page 129
container_title Toxicology and applied pharmacology
container_volume 179
creator Governa, Mario
Fenoglio, Ivana
Amati, Monica
Valentino, Matteo
Bolognini, Lucia
Coloccini, Sabrina
Volpe, Anna Rita
Carmignani, Marco
Fubini, Bice
description The effects of the same form of crystalline silica variously modified were compared to investigate the mechanisms by which silica activates C5 molecules. After incubation in human plasma, silica generated C5a-type fragments that stimulated polymorphonuclear leukocyte chemotaxis. This activity was totally abolished when plasma, adsorbed with antiserum against C5a or thermally inactivated, was used. Pretreatment of plasma with deferoxamine, 1,3 dimethyl-2-thiourea, or aprotinin markedly inhibited or totally abolished C5 activation. Finally, a significant increase in kallikrein activity was detected after incubation of silica particles in plasma. The results seem to indicate that the activation of C5 by crystalline silica occurs through a complex mechanism: the redox-active iron possibly present at the silica surface catalyzes, via Haber–Weiss cycles, the production of hydroxyl radicals, which in turn convert native C5 to an oxidized C5-like form. This product is then cleaved by kallikrein, activated by the same silica particles, yielding oxidized C5a with the same functional properties as C5a. The different types of the same form of silica exhibited different reactivity. Two separate properties of the dusts seem to contribute to C5 activation: the potential to release hydroxyl radicals and the extent of C5 adsorption at the surface. The degree of surface hydrophobicity/hydrophilicity appeared sufficient to explain the different responses.
doi_str_mv 10.1006/taap.2002.9351
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_18309053</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0041008X02993518</els_id><sourcerecordid>18309053</sourcerecordid><originalsourceid>FETCH-LOGICAL-c401t-47fa4edcfc4fe456cb2ec5d64b0c4f2fb6815153e425b400605668883c80106e3</originalsourceid><addsrcrecordid>eNp1kUFv1DAQhS0EokvhyhH5Arcs49gxybGKum3VSqAWJG6R40y6po4TbGfR_jT-Hc7uSj1xsvT8vTejeYS8Z7BmAPJzVGpa5wD5uuIFe0FWDCqZAef8JVkBCJYBlD_PyJsQfgFAJQR7Tc4Yq0DmIl-Rv7VFtVOPSMeexi3SjenjltbjMI0OXVzk63lQ7iBZHBZNuY7eYzKGg03Rh8maSL_5sZt1pH_MklCozJonpBc6mp2Je9ruae33ISprjUP6YKzRKs304_y4pRuPSO9VlzRLr9ChV9GM7jDrdrE8eTTumHb4eUte9coGfHd6z8mPzeX3-jq7-3p1U1_cZVoAi5n40iuBne616FEUUrc56qKTooWk5H0rS1awgqPIi1akk0IhZVmWXJfAQCI_J5-OuZMff88YYjOYoNFa5XCcQ8NKDhUUPIHrI6j9GILHvpm8GZTfNwyapaxmKatZymqWspLhwyl5bgfsnvFTOwn4eAJUSGfpvXLahGeOS1ZJJhNXHjlMd9gZ9E3QBp3GznjUselG878d_gGrjrJu</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18309053</pqid></control><display><type>article</type><title>Cleavage of the Fifth Component of Human Complement and Release of a Split Product with C5a-like Activity by Crystalline Silica through Free Radical Generation and Kallikrein Activation</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Governa, Mario ; Fenoglio, Ivana ; Amati, Monica ; Valentino, Matteo ; Bolognini, Lucia ; Coloccini, Sabrina ; Volpe, Anna Rita ; Carmignani, Marco ; Fubini, Bice</creator><creatorcontrib>Governa, Mario ; Fenoglio, Ivana ; Amati, Monica ; Valentino, Matteo ; Bolognini, Lucia ; Coloccini, Sabrina ; Volpe, Anna Rita ; Carmignani, Marco ; Fubini, Bice</creatorcontrib><description>The effects of the same form of crystalline silica variously modified were compared to investigate the mechanisms by which silica activates C5 molecules. After incubation in human plasma, silica generated C5a-type fragments that stimulated polymorphonuclear leukocyte chemotaxis. This activity was totally abolished when plasma, adsorbed with antiserum against C5a or thermally inactivated, was used. Pretreatment of plasma with deferoxamine, 1,3 dimethyl-2-thiourea, or aprotinin markedly inhibited or totally abolished C5 activation. Finally, a significant increase in kallikrein activity was detected after incubation of silica particles in plasma. The results seem to indicate that the activation of C5 by crystalline silica occurs through a complex mechanism: the redox-active iron possibly present at the silica surface catalyzes, via Haber–Weiss cycles, the production of hydroxyl radicals, which in turn convert native C5 to an oxidized C5-like form. This product is then cleaved by kallikrein, activated by the same silica particles, yielding oxidized C5a with the same functional properties as C5a. The different types of the same form of silica exhibited different reactivity. Two separate properties of the dusts seem to contribute to C5 activation: the potential to release hydroxyl radicals and the extent of C5 adsorption at the surface. The degree of surface hydrophobicity/hydrophilicity appeared sufficient to explain the different responses.</description><identifier>ISSN: 0041-008X</identifier><identifier>EISSN: 1096-0333</identifier><identifier>DOI: 10.1006/taap.2002.9351</identifier><identifier>PMID: 11906242</identifier><identifier>CODEN: TXAPA9</identifier><language>eng</language><publisher>San Diego, CA: Elsevier Inc</publisher><subject>Adult ; Biological and medical sciences ; C5 activation ; Chemical and industrial products toxicology. Toxic occupational diseases ; Chemotaxis - drug effects ; complement ; Complement Activation - drug effects ; Complement C5 - antagonists &amp; inhibitors ; Complement C5 - metabolism ; Complement C5a - metabolism ; crystalline silica ; Deferoxamine - pharmacology ; Female ; Free Radical Scavengers - pharmacology ; Humans ; Hydroxyl Radical - metabolism ; Inorganic dusts (pneumoconiosises) and organic dusts (byssinosis etc.) ; Iron - pharmacology ; Iron Chelating Agents - pharmacology ; kallikrein ; Kallikreins - blood ; Male ; Medical sciences ; Middle Aged ; Neutrophils - drug effects ; Quartz - pharmacology ; Quartz - toxicity ; silicon dioxide ; Thiourea - analogs &amp; derivatives ; Thiourea - pharmacology ; Toxicology ; Zymosan - pharmacology</subject><ispartof>Toxicology and applied pharmacology, 2002-03, Vol.179 (3), p.129-136</ispartof><rights>2002 Elsevier Science (USA)</rights><rights>2002 INIST-CNRS</rights><rights>Copyright 2002 Elsevier Science (USA).</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c401t-47fa4edcfc4fe456cb2ec5d64b0c4f2fb6815153e425b400605668883c80106e3</citedby><cites>FETCH-LOGICAL-c401t-47fa4edcfc4fe456cb2ec5d64b0c4f2fb6815153e425b400605668883c80106e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0041008X02993518$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=13619616$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11906242$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Governa, Mario</creatorcontrib><creatorcontrib>Fenoglio, Ivana</creatorcontrib><creatorcontrib>Amati, Monica</creatorcontrib><creatorcontrib>Valentino, Matteo</creatorcontrib><creatorcontrib>Bolognini, Lucia</creatorcontrib><creatorcontrib>Coloccini, Sabrina</creatorcontrib><creatorcontrib>Volpe, Anna Rita</creatorcontrib><creatorcontrib>Carmignani, Marco</creatorcontrib><creatorcontrib>Fubini, Bice</creatorcontrib><title>Cleavage of the Fifth Component of Human Complement and Release of a Split Product with C5a-like Activity by Crystalline Silica through Free Radical Generation and Kallikrein Activation</title><title>Toxicology and applied pharmacology</title><addtitle>Toxicol Appl Pharmacol</addtitle><description>The effects of the same form of crystalline silica variously modified were compared to investigate the mechanisms by which silica activates C5 molecules. After incubation in human plasma, silica generated C5a-type fragments that stimulated polymorphonuclear leukocyte chemotaxis. This activity was totally abolished when plasma, adsorbed with antiserum against C5a or thermally inactivated, was used. Pretreatment of plasma with deferoxamine, 1,3 dimethyl-2-thiourea, or aprotinin markedly inhibited or totally abolished C5 activation. Finally, a significant increase in kallikrein activity was detected after incubation of silica particles in plasma. The results seem to indicate that the activation of C5 by crystalline silica occurs through a complex mechanism: the redox-active iron possibly present at the silica surface catalyzes, via Haber–Weiss cycles, the production of hydroxyl radicals, which in turn convert native C5 to an oxidized C5-like form. This product is then cleaved by kallikrein, activated by the same silica particles, yielding oxidized C5a with the same functional properties as C5a. The different types of the same form of silica exhibited different reactivity. Two separate properties of the dusts seem to contribute to C5 activation: the potential to release hydroxyl radicals and the extent of C5 adsorption at the surface. The degree of surface hydrophobicity/hydrophilicity appeared sufficient to explain the different responses.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>C5 activation</subject><subject>Chemical and industrial products toxicology. Toxic occupational diseases</subject><subject>Chemotaxis - drug effects</subject><subject>complement</subject><subject>Complement Activation - drug effects</subject><subject>Complement C5 - antagonists &amp; inhibitors</subject><subject>Complement C5 - metabolism</subject><subject>Complement C5a - metabolism</subject><subject>crystalline silica</subject><subject>Deferoxamine - pharmacology</subject><subject>Female</subject><subject>Free Radical Scavengers - pharmacology</subject><subject>Humans</subject><subject>Hydroxyl Radical - metabolism</subject><subject>Inorganic dusts (pneumoconiosises) and organic dusts (byssinosis etc.)</subject><subject>Iron - pharmacology</subject><subject>Iron Chelating Agents - pharmacology</subject><subject>kallikrein</subject><subject>Kallikreins - blood</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Neutrophils - drug effects</subject><subject>Quartz - pharmacology</subject><subject>Quartz - toxicity</subject><subject>silicon dioxide</subject><subject>Thiourea - analogs &amp; derivatives</subject><subject>Thiourea - pharmacology</subject><subject>Toxicology</subject><subject>Zymosan - pharmacology</subject><issn>0041-008X</issn><issn>1096-0333</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kUFv1DAQhS0EokvhyhH5Arcs49gxybGKum3VSqAWJG6R40y6po4TbGfR_jT-Hc7uSj1xsvT8vTejeYS8Z7BmAPJzVGpa5wD5uuIFe0FWDCqZAef8JVkBCJYBlD_PyJsQfgFAJQR7Tc4Yq0DmIl-Rv7VFtVOPSMeexi3SjenjltbjMI0OXVzk63lQ7iBZHBZNuY7eYzKGg03Rh8maSL_5sZt1pH_MklCozJonpBc6mp2Je9ruae33ISprjUP6YKzRKs304_y4pRuPSO9VlzRLr9ChV9GM7jDrdrE8eTTumHb4eUte9coGfHd6z8mPzeX3-jq7-3p1U1_cZVoAi5n40iuBne616FEUUrc56qKTooWk5H0rS1awgqPIi1akk0IhZVmWXJfAQCI_J5-OuZMff88YYjOYoNFa5XCcQ8NKDhUUPIHrI6j9GILHvpm8GZTfNwyapaxmKatZymqWspLhwyl5bgfsnvFTOwn4eAJUSGfpvXLahGeOS1ZJJhNXHjlMd9gZ9E3QBp3GznjUselG878d_gGrjrJu</recordid><startdate>20020315</startdate><enddate>20020315</enddate><creator>Governa, Mario</creator><creator>Fenoglio, Ivana</creator><creator>Amati, Monica</creator><creator>Valentino, Matteo</creator><creator>Bolognini, Lucia</creator><creator>Coloccini, Sabrina</creator><creator>Volpe, Anna Rita</creator><creator>Carmignani, Marco</creator><creator>Fubini, Bice</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>20020315</creationdate><title>Cleavage of the Fifth Component of Human Complement and Release of a Split Product with C5a-like Activity by Crystalline Silica through Free Radical Generation and Kallikrein Activation</title><author>Governa, Mario ; Fenoglio, Ivana ; Amati, Monica ; Valentino, Matteo ; Bolognini, Lucia ; Coloccini, Sabrina ; Volpe, Anna Rita ; Carmignani, Marco ; Fubini, Bice</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c401t-47fa4edcfc4fe456cb2ec5d64b0c4f2fb6815153e425b400605668883c80106e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>C5 activation</topic><topic>Chemical and industrial products toxicology. Toxic occupational diseases</topic><topic>Chemotaxis - drug effects</topic><topic>complement</topic><topic>Complement Activation - drug effects</topic><topic>Complement C5 - antagonists &amp; inhibitors</topic><topic>Complement C5 - metabolism</topic><topic>Complement C5a - metabolism</topic><topic>crystalline silica</topic><topic>Deferoxamine - pharmacology</topic><topic>Female</topic><topic>Free Radical Scavengers - pharmacology</topic><topic>Humans</topic><topic>Hydroxyl Radical - metabolism</topic><topic>Inorganic dusts (pneumoconiosises) and organic dusts (byssinosis etc.)</topic><topic>Iron - pharmacology</topic><topic>Iron Chelating Agents - pharmacology</topic><topic>kallikrein</topic><topic>Kallikreins - blood</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Neutrophils - drug effects</topic><topic>Quartz - pharmacology</topic><topic>Quartz - toxicity</topic><topic>silicon dioxide</topic><topic>Thiourea - analogs &amp; derivatives</topic><topic>Thiourea - pharmacology</topic><topic>Toxicology</topic><topic>Zymosan - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Governa, Mario</creatorcontrib><creatorcontrib>Fenoglio, Ivana</creatorcontrib><creatorcontrib>Amati, Monica</creatorcontrib><creatorcontrib>Valentino, Matteo</creatorcontrib><creatorcontrib>Bolognini, Lucia</creatorcontrib><creatorcontrib>Coloccini, Sabrina</creatorcontrib><creatorcontrib>Volpe, Anna Rita</creatorcontrib><creatorcontrib>Carmignani, Marco</creatorcontrib><creatorcontrib>Fubini, Bice</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Toxicology and applied pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Governa, Mario</au><au>Fenoglio, Ivana</au><au>Amati, Monica</au><au>Valentino, Matteo</au><au>Bolognini, Lucia</au><au>Coloccini, Sabrina</au><au>Volpe, Anna Rita</au><au>Carmignani, Marco</au><au>Fubini, Bice</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cleavage of the Fifth Component of Human Complement and Release of a Split Product with C5a-like Activity by Crystalline Silica through Free Radical Generation and Kallikrein Activation</atitle><jtitle>Toxicology and applied pharmacology</jtitle><addtitle>Toxicol Appl Pharmacol</addtitle><date>2002-03-15</date><risdate>2002</risdate><volume>179</volume><issue>3</issue><spage>129</spage><epage>136</epage><pages>129-136</pages><issn>0041-008X</issn><eissn>1096-0333</eissn><coden>TXAPA9</coden><abstract>The effects of the same form of crystalline silica variously modified were compared to investigate the mechanisms by which silica activates C5 molecules. After incubation in human plasma, silica generated C5a-type fragments that stimulated polymorphonuclear leukocyte chemotaxis. This activity was totally abolished when plasma, adsorbed with antiserum against C5a or thermally inactivated, was used. Pretreatment of plasma with deferoxamine, 1,3 dimethyl-2-thiourea, or aprotinin markedly inhibited or totally abolished C5 activation. Finally, a significant increase in kallikrein activity was detected after incubation of silica particles in plasma. The results seem to indicate that the activation of C5 by crystalline silica occurs through a complex mechanism: the redox-active iron possibly present at the silica surface catalyzes, via Haber–Weiss cycles, the production of hydroxyl radicals, which in turn convert native C5 to an oxidized C5-like form. This product is then cleaved by kallikrein, activated by the same silica particles, yielding oxidized C5a with the same functional properties as C5a. The different types of the same form of silica exhibited different reactivity. Two separate properties of the dusts seem to contribute to C5 activation: the potential to release hydroxyl radicals and the extent of C5 adsorption at the surface. The degree of surface hydrophobicity/hydrophilicity appeared sufficient to explain the different responses.</abstract><cop>San Diego, CA</cop><pub>Elsevier Inc</pub><pmid>11906242</pmid><doi>10.1006/taap.2002.9351</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0041-008X
ispartof Toxicology and applied pharmacology, 2002-03, Vol.179 (3), p.129-136
issn 0041-008X
1096-0333
language eng
recordid cdi_proquest_miscellaneous_18309053
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adult
Biological and medical sciences
C5 activation
Chemical and industrial products toxicology. Toxic occupational diseases
Chemotaxis - drug effects
complement
Complement Activation - drug effects
Complement C5 - antagonists & inhibitors
Complement C5 - metabolism
Complement C5a - metabolism
crystalline silica
Deferoxamine - pharmacology
Female
Free Radical Scavengers - pharmacology
Humans
Hydroxyl Radical - metabolism
Inorganic dusts (pneumoconiosises) and organic dusts (byssinosis etc.)
Iron - pharmacology
Iron Chelating Agents - pharmacology
kallikrein
Kallikreins - blood
Male
Medical sciences
Middle Aged
Neutrophils - drug effects
Quartz - pharmacology
Quartz - toxicity
silicon dioxide
Thiourea - analogs & derivatives
Thiourea - pharmacology
Toxicology
Zymosan - pharmacology
title Cleavage of the Fifth Component of Human Complement and Release of a Split Product with C5a-like Activity by Crystalline Silica through Free Radical Generation and Kallikrein Activation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T10%3A54%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cleavage%20of%20the%20Fifth%20Component%20of%20Human%20Complement%20and%20Release%20of%20a%20Split%20Product%20with%20C5a-like%20Activity%20by%20Crystalline%20Silica%20through%20Free%20Radical%20Generation%20and%20Kallikrein%20Activation&rft.jtitle=Toxicology%20and%20applied%20pharmacology&rft.au=Governa,%20Mario&rft.date=2002-03-15&rft.volume=179&rft.issue=3&rft.spage=129&rft.epage=136&rft.pages=129-136&rft.issn=0041-008X&rft.eissn=1096-0333&rft.coden=TXAPA9&rft_id=info:doi/10.1006/taap.2002.9351&rft_dat=%3Cproquest_cross%3E18309053%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=18309053&rft_id=info:pmid/11906242&rft_els_id=S0041008X02993518&rfr_iscdi=true